Clinical trial
IGF-I Induced Muscle Glucose Uptake and Interstitial IGF-I Concentrations
NCT01588093
Study timeline
Study start (unknown)2011-04-01Date precision: month
Registry last updated2012-04-30
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 1 Diabetes Mellitusunresolved
Interventions
IncrelexDRUG · verified · RxNorm: Increlex
0.9% SalineDRUG
Sponsors & collaborators
Peter Banglead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01588093 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.